BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 18335793)

  • 1. Spectrum of histological features in non-alcoholic fatty liver disease.
    Vasdev N; Kakati AG; Saigal S; Nayak NC
    Natl Med J India; 2007; 20(6):282-7. PubMed ID: 18335793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
    Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological assessment of non-alcoholic fatty liver disease.
    Hübscher SG
    Histopathology; 2006 Nov; 49(5):450-65. PubMed ID: 17064291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of steatosis and inflammation on liver fibrosis in chronic hepatitis C.
    Nieminen U; Arkkila PE; Kärkkäinen P; Färkkilä MA
    Liver Int; 2009 Feb; 29(2):153-8. PubMed ID: 18482270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: non-alcoholic fatty liver disease and hepatitis C--risk factors and clinical implications.
    Sanyal AJ
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():48-51. PubMed ID: 16225473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathology and biopsy assessment of non-alcoholic fatty liver disease.
    Straub BK; Schirmacher P
    Dig Dis; 2010; 28(1):197-202. PubMed ID: 20460911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk.
    Tahan V; Canbakan B; Balci H; Dane F; Akin H; Can G; Hatemi I; Olgac V; Sonsuz A; Ozbay G; Yurdakul I; Senturk H
    Hepatogastroenterology; 2008; 55(85):1433-8. PubMed ID: 18795706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations.
    Younossi ZM; Gramlich T; Liu YC; Matteoni C; Petrelli M; Goldblum J; Rybicki L; McCullough AJ
    Mod Pathol; 1998 Jun; 11(6):560-5. PubMed ID: 9647594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The comparison of scoring scales for liver biopsy assessment in morbidly obese patients undergoing bariatric surgery.
    Ziolkowski A; Wylezol M; Kukla M; Zwirska-Korczala K; Berdowska A; Pardela M; Gabriel A
    Obes Surg; 2005 Oct; 15(9):1309-14. PubMed ID: 16259893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease.
    Merriman RB; Ferrell LD; Patti MG; Weston SR; Pabst MS; Aouizerat BE; Bass NM
    Hepatology; 2006 Oct; 44(4):874-80. PubMed ID: 17006934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels.
    Wong VW; Wong GL; Tsang SW; Hui AY; Chan AW; Choi PC; Chim AM; Chu S; Chan FK; Sung JJ; Chan HL
    Aliment Pharmacol Ther; 2009 Feb; 29(4):387-96. PubMed ID: 19035982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proposal for a histological scoring and grading system for non-alcoholic fatty liver disease.
    Mendler MH; Kanel G; Govindarajan S
    Liver Int; 2005 Apr; 25(2):294-304. PubMed ID: 15780053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-alcoholic fatty liver disease in liver transplant recipients: another story of "seed and soil".
    Dumortier J; Giostra E; Belbouab S; Morard I; Guillaud O; Spahr L; Boillot O; Rubbia-Brandt L; Scoazec JY; Hadengue A
    Am J Gastroenterol; 2010 Mar; 105(3):613-20. PubMed ID: 20040915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic fatty liver disease in Malaysia: a demographic, anthropometric, metabolic and histological study.
    Malik A; Cheah PL; Hilmi IN; Chan SP; Goh KL
    J Dig Dis; 2007 Feb; 8(1):58-64. PubMed ID: 17261137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease.
    Ekstedt M; Franzén LE; Holmqvist M; Bendtsen P; Mathiesen UL; Bodemar G; Kechagias S
    Scand J Gastroenterol; 2009; 44(3):366-74. PubMed ID: 19016382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and histological features of non-alcoholic fatty liver disease in Hong Kong Chinese.
    Wong VW; Chan HL; Hui AY; Chan KF; Liew CT; Chan FK; Sung JJ
    Aliment Pharmacol Ther; 2004 Jul; 20(1):45-9. PubMed ID: 15225170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathology of pediatric nonalcoholic fatty liver disease.
    Schwimmer JB; Behling C; Newbury R; Deutsch R; Nievergelt C; Schork NJ; Lavine JE
    Hepatology; 2005 Sep; 42(3):641-9. PubMed ID: 16116629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors.
    Peng D; Han Y; Ding H; Wei L
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1082-8. PubMed ID: 18707599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic fatty liver disease. Correlation with histology and viral hepatitis.
    Akyol G; Erdem O; Yilmaz G
    Saudi Med J; 2005 Dec; 26(12):1904-10. PubMed ID: 16380770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.